RARA CRAFT DATABASE for FDA Medical Devices

FDA Device Decisions, August 2026: A Blood-Drawing Robot, a Glucose-Ketone CGM and Five New De Novo Classifications

日本語版

One of FDA's De Novo grants in August 2026 went to a robot that finds a vein by ultrasound and draws blood on its own. Vitestro's Aletta (DEN250046) is indicated for autonomous, ultrasound-guided venipuncture and blood collection for diagnostic purposes in adult outpatients, monitored by a trained phlebotomist. The grant created a new classification, "robotic peripheral venous blood collection system."

The same month, Abbott's Libre Duo 10 Day (DEN250049) was granted as well: a single sensor that monitors both glucose and ketones (beta-hydroxybutyrate), and another new classification.

Counting records held in RA Craft Database (decisions through August 31, 2026, tallied October 6), FDA cleared 248 510(k)s in August, granted 5 De Novo requests and approved 3 original PMAs. These counts have not been reconciled with FDA's own figures. The data are updated monthly, and recent months in particular can grow in later tallies.

Counts by pathway

August next to July and to August 2025, with records assigned to a month by FDA decision date.

PathwayAugust 2026July 2026August 2025
510(k)248278251
De Novo551
PMA (original)346
PMA supplement157214179

Records held in RA Craft Database, decisions through August 31, 2026.

510(k) clearances were 30 fewer than in July and close to August 2025 (251). De Novo grants matched July's five, against one a year earlier.

August's 510(k)s spread across 172 product codes. QIH (automated radiological image processing software) led with 8, followed by OHS (light based over the counter wrinkle reduction) with 5, then DXN (non-invasive blood pressure measurement system), GEX (powered laser surgical instrument), KNW (biopsy instrument) and NRY (thrombus retriever catheter) with 4 each. A single 510(k) can carry more than one product code, so per-code counts can add up to more than the number of submissions.

De Novo: five new classifications

August's five De Novo grants are below. The classification names come from each device's Classification Order.

NumberDevice (requester)Classification (21 CFR)Class
DEN250046Aletta® Autonomous Robotic Phlebotomy Device (Vitestro)Robotic peripheral venous blood collection system (880.6975)II
DEN250049Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System (Abbott Diabetes Care)Integrated continuous glucose ketone monitoring system (862.1354)II
DEN250043Qoramatic Automated Stool Management (Cm Technologies, Inc.)Powered fecal management system (876.5230)II
DEN250067ReneuRx (Neural Ice) (Brixton Biosciences)Injectable for thermal treatment of musculoskeletal pain (888.3048)II
DEN250026Avulux (Matap II, LLC)Light Attenuation Lenses for Migraine-associated Light Sensitivity (882.5811)I

"21 CFR" refers to Title 21 of the Code of Federal Regulations, where FDA's regulations are codified.

Aletta (DEN250046) automates a procedure clinicians perform every day. Its classification carries ten special controls, among them clinical and non-clinical performance testing, human factors and usability testing, software verification and validation, electromagnetic compatibility, biocompatibility, sterilization and reprocessing validation, and labeling. A device that places a needle on its own, under software control, with reusable components, touches most of the categories FDA uses.

Libre Duo 10 Day (DEN250049) is indicated for the management of diabetes in people aged 2 and older and monitors glucose and ketone levels in real time. Rising ketones can signal diabetic ketoacidosis, so tracking them on the same sensor as glucose has clinical value. The indications also cover alarms, trend detection, use in place of fingerstick testing for treatment decisions, and autonomous communication with connected devices. The seven special controls include design verification and validation with clinical accuracy data, a secure and reliable data transmission strategy, interfering-substance testing, usability, and labeling with sensor performance data.

Qoramatic (DEN250043) is a powered system that diverts and collects liquid or semi-liquid stool in bedridden adult patients to minimize skin contact. ReneuRx (DEN250067) manages knee pain in adults with symptomatic osteoarthritis by introducing a multiphase suspension around the target sensory nerve to inhibit nerve signaling; its special controls include animal performance testing.

Avulux (DEN250026) is the one Class I device of the five: lenses that block light at 480 nm and 590 nm to decrease the impact of light sensitivity in patients aged 12 and older diagnosed with episodic migraine. FDA found general controls sufficient and exempted the device type from 510(k). Not every De Novo ends in Class II, and devices of this type can now go to market without a 510(k), within the limits of the exemption.

All five Classification Orders are already posted on FDA's site (checked October 5). If one of these categories is close to your device, its classification name and special controls are worth reading now, before a 510(k) under the new code arrives.

Original PMAs: three approvals

August's three original PMA approvals:

  • BAGUERA® C Cervical Disc Prosthesis (P250042, Spineart USA, Inc., August 10): disc reconstruction at one or two contiguous levels from C3 to C7 after discectomy, in skeletally mature patients
  • Dilight™ Overnight Orthokeratology Contact Lens (P220015, Tianjin MasterVision Technology Co., Ltd., August 5): an overnight orthokeratology lens
  • RefluxStop® Device (P250018, Implantica CE Reflux, Ltd., August 20): an implant for the treatment of gastroesophageal reflux disease (GERD)

The "22" in P220015 is the year the PMA was received; approval came in August 2026. The approval order for RefluxStop refers to a post-market study, REVEAL, to assess safety and effectiveness. Post-approval studies are a common condition of PMA approval.

For each original PMA, FDA publishes a Summary of Safety and Effectiveness Data (SSED). August also brought 157 PMA supplements, which cover changes to already approved PMA devices among other things.

Star the five De Novo records

Open DEN250046, DEN250049 and the other August De Novo records on Search and star (☆) them into My Workspace, so you can compare them with the first 510(k)s that follow under each code. Typing SIW or SJD into the Product Code field lists the records under each new classification.

Note: months are assigned by FDA decision date, and counts can change as the data are updated each month.

RA Craft Database is an independent service and is not affiliated with or endorsed by the U.S. FDA. Articles are for general information on product development and regulatory research; they are not legal or regulatory advice for a specific device. Official FDA documents remain the authoritative source.

← All articles